LGN Partner Brian Clark has been named Co-Lead Counsel in the Peanut Farmer Antitrust Litigation
/in Brian D. Clark, News /by James McEwenLockridge Grindal Nauen Environmental Law Team Selected as a Tier 1 Metropolitan “Best Law Firm”
/in News /by James McEwenKaren Hanson Riebel Named Co-Lead Counsel in Capital One Data Breach Case
/in Karen Hanson Riebel, News /by dwilliams@razorrank.comDavid Zoll Talks Environmental Impact Statement Process On Potential Twin Metals Mine
/in David J. Zoll, News /by dwilliams@razorrank.comLGN Partner Joe Bruckner Presents at Cambridge Antitrust Litigation Forum
/in News, W. Joseph Bruckner /by James McEwenLGN Federal Relations Policy Brief: Federal Budget
/in News, Uncategorized /by dwilliams@razorrank.comCongressional leaders and the White House announced a budget deal at the end of July to raise federal spending limits for fiscal years 2020 and 2021 and outlined an informal agreement to avoid partisan policy riders, clearing a path for action on fiscal 2020 appropriations this fall. The Senate passed the budget bill by a vote of 67-28 after the House passed the same measure by a vote of 284-149. The two-year budget deal sets top-line spending levels, but Congress still needs to approve a package of 12 appropriations bills, or pass a temporary funding extension, to avoid a government shutdown when current funding expires at the end of this month.
Read moreLGN to co-host CLE with The Advocates for Human Rights
/in News, Uncategorized /by dwilliams@razorrank.comLockridge Grindal Nauen will be co-hosting a CLE session on the topic of labor trafficking alongside The Advocates for Human Rights on Friday September 6th from 9:00-10:30am at our offices in Minneapolis.
Read moreLGN Federal Relations Policy Brief: Health Care & Prescription Drugs
/in News, Uncategorized /by dwilliams@razorrank.comThe final four months of 2019 will be a “now-or-never” time for Congress to take substantive action to lower prescription drug prices. So far in the 116th Congress, the House and Senate have each taken actions on this issue. The House held nearly a dozen congressional hearings to examine the rise of drug prices, marked up and reported out about a half-dozen bills from three different committees. Of these, the House Energy and Commerce (E&C) Committee dedicated more hearings on the issue and also seemed to have packaged together a broader bill than the other committees. The More Efficient Tools to Realize Information for Consumers (METRIC) Act (H.R. 2296), passed the E&C Committee last month shortly before the House left town for the August recess. In short, the METRIC Act would increase public disclosures of drug pricing information as well as more oversight over pharmacy benefit managers (PBMs). The bill awaits House floor consideration once the House comes back from its recess in September.
Read morePractices
Practices Cont.
- Federal Government Relations
- Government Representation
- Health Care Law
- Intellectual Property
- Mass Torts
- Personal Injury, Defective Drugs, and Medical Devices
- Political Law
- Products Liability & Consumer Fraud Litigation
- Real Estate & Land Use
- Securities Litigation
- State and Local Government Relations
- Tribal Government Representation
Minneapolis
Lockridge Grindal Nauen PLLP
100 Washington Avenue South
Suite 2200
Minneapolis, Minnesota 55401-2159
Phone: 612-339-6900
Chicago
Lockridge Grindal Nauen PLLP
1165 N. Clark Street
Suite 700
Chicago, IL 60610
Phone: 312-205-8968
Boston
Lockridge Grindal Nauen PLLP
265 Franklin Street
Suite 1702
Boston, MA 02110
Phone: 617-535-3763